CADMIUM AND CADMIUM COMPOUNDS
Cadmium was identified as a toxic air contaminant under California's
air toxics program (AB 1807) in 1986.
Cadmium compounds are federal hazardous air pollutants and were identified as
toxic air contaminants in April 1993 under AB 2728.
CAS Registry Number: 7440-43-9 Cd
Molecular Formula: Cd
Cadmium is a malleable, silver-white, odorless metal. It is produced
as a byproduct of zinc, lead or copper ore smelting, especially zinc (Sittig,
1991). Cadmium is insoluble in water. It is soluble in acid ammonium nitrate,
but not in sulfuric acid (Merck, 1989; HSDB, 1995). Cadmium compounds range
in solubility in water from quite soluble to practically insoluble (ATSDR,
1992). In its elemental form, cadmium is resistant to corrosion by alkalies
and salt water, and retains its metallic luster in air. The most common
oxidation state of cadmium is +2, although a few cadmium compounds occur
in the +1 oxidation state (ARB, 1986c). See Table 1 for information about
the physical properties of cadmium compounds.
Physical Properties of Cadmium
Molecular Weight: | 112.41 |
Valence: |
+2 |
Boiling Point: | 765 oC |
Melting Point: | 321 oC |
Vapor Pressure: | 1 mm Hg at 394 oC |
Density/Specific Gravity: | 8.65 at 25 oC (water = 1) |
SOURCES AND EMISSIONS
A. Sources
Cadmium compounds are used in the metal plating and battery industry. Cadmium sulfide and sulfoselenide are used in pigments. Cadmium compounds are used as stabilizing agents in many polyvinyl chloride products. Cadmium sulfide and cadmium telluride are used in the electronics industry to produce photocells and light emitting diodes. Cadmium metal alloyed with copper is used in the production of automobile radiators. Cadmium sulfide is used as a curing agent in tires (ARB, 1986c). Cadmium acetate is used in ceramics, textile dyeing, printing, and electroplating. Cadmium bromide is used in photography, engraving, and lithography. Cadmium chloride is used in dyeing and printing of fabrics, in electronics component manufacture, and in photography. Cadmium oxide is used in electroplating, manufacture of cadmium electrodes, in semiconductors, and in glass and ceramic glazes
(Sittig, 1991). Cadmium is a component of diesel fuel, gasoline, and
lubricating oil. Also, it is present in vehicle tires and consequently
in the particles resulting from tire wear (ARB, 1986c).
As of February 22, 1983, cadmium sebacate and cadmium succinate are
no longer registered for pesticidal use in California. And, as of January
15, 1985, cadmium chloride is no longer registered for pesticidal use in
California (DPR, 1996).
The primary stationary sources that have reported emissions of cadmium in California are electrical services, gold and silver ore mining, and structural clay products manufacturing
(ARB, 1997b).
B. Emissions
The total emissions of cadmium from stationary sources in California
are estimated to be at least 3,900 pounds per year based on data reported
under the Air Toxics "Hot Spots" Program (AB 2588) (ARB, 1997b).
In January 1993, the Air Resources Board (ARB) adopted an airborne toxics
control measure for non-ferrous metal melting operations. This control
measure is expected to reduce emissions of arsenic, cadmium, and nickel
by 99 percent (ARB, 1992f).
C. Natural Occurrence
Coal and other fossil fuels contain cadmium and their combustion releases
the element into the environment. Cadmium occurs in sulfide ore (greenockite)
containing zinc sulfide and with lead and copper ores containing zinc.
Cadmium has been detected in carbonaceous shales and phosphatic rock. Volcanic
emissions contain cadmium-enriched aerosols (HSDB, 1995).
AMBIENT CONCENTRATIONS
Cadmium and its compounds are routinely monitored by the statewide Air
Resources Board (ARB) air toxics network. The network's mean concentration
of cadmium including its species from July 1995 through June 1996 is estimated
to be 0.411 nanogram per cubic meter (ng/m3) (ARB, 1997c).
When cadmium and cadmium compounds were formally identified as a toxic
air contaminant, the ARB estimated a population-weighted annual concentration
for 10 million people of between 1.0 and 2.5 ng/m3, of which
1 million people are exposed to an average cadmium concentration between
1.8 and 5.6 ng/m3 (ARB, 1986c).
The United States Environmental Protection Agency (U.S. EPA) has also
reported concentrations of cadmium from one study area during 1985. The
overall range of concentrations from this area were from 0.3 to 4.1 ng/m3,
with an overall mean concentration of 1.2 ng/m3 (U.S. EPA, 1993a).
INDOOR SOURCES AND CONCENTRATIONS
Environmental tobacco smoke is an indoor source of cadmium (NRC, 1986).
In a field study conducted in southern California, investigators collected
particles (PM10) inside 178 homes and analyzed the particle
samples for selected elements, including cadmium. Two consecutive 12-hour
samples were collected inside and immediately outside each home. Cadmium
was present in measurable amounts in less than 10 percent of the samples
(Clayton et al., 1993).
A southern California in-vehicle study measured an average cadmium concentration
of 1 ng/m3 and a maximum concentration of 8 ng/m3
(Shikiya et al., 1989).
ATMOSPHERIC PERSISTENCE
Cadmium and cadmium compounds are expected to be particle-associated in the atmosphere, and hence subject to wet and dry deposition. The average half-life and lifetime life for particles and particle-associated chemicals in the atmosphere is estimated to be about 3.5 to 10 days and
5 to 15 days, respectively (Balkanski et al., 1993; Atkinson, 1995).
AB 2588 RISK ASSESSMENT INFORMATION
The Office of Environmental Health Hazard Assessment reviews risk assessments submitted under the Air Toxics "Hot Spots" Program (AB 2588). Of the risk assessments reviewed as of April 1996, cadmium and cadmium compounds were the major contributors to the overall cancer risk in 14 of the approximately 550 risk assessments reporting a total cancer risk equal to or greater than 1 in 1 million and contributed to the total cancer risk in 222 of the these risk assessments. Cadmium and cadmium compounds also were also the major contributors to the overall cancer risk in 4 of the approximately 130 risk assessments reporting a total cancer risk
equal to or greater than 10 in 1 million, and contributed to the total
cancer risk in 70 of these risk assessments (OEHHA, 1996a).
For non-cancer health effects, cadmium and cadmium compounds contributed
to the total hazard index in 31 of the approximately 89 risk assessments
reporting a total chronic hazard
index greater than 1. Cadmium and cadmium compounds also contributed
to the total hazard index in 5 of the approximately 107 risk assessments
reporting a total acute hazard index greater than 1 (OEHHA, 1996b).
HEALTH EFFECTS
Probable routes of human exposure to cadmium are inhalation and ingestion.
Non-Cancer: Although ingestion is the major source of exposure, only
1 to 10 percent of ingested cadmium appears to be absorbed systemically.
Pulmonary absorption of inhaled cadmium is estimated to range from 10 to
50 percent of deposited cadmium. The biological half-life of cadmium in
humans has been estimated to range from 10 to 30 years. Cadmium has moderate
acute toxicity, producing gastrointestinal or pulmonary irritation effects
from ingestion or inhalation, respectively. Subchronic and chronic exposures
to cadmium have been associated with renal, cardiovascular, endocrine,
hepatic, bone, hematological, and immunological effects. Respiratory conditions
include bronchiolitis and emphysema. The U.S. EPA's Office of Air Quality
Planning and Standards, for a hazard ranking under Section 112(g) of the
Clean Air Act Amendments, considers cadmium oxide to be a "high concern"
pollutant based on severe acute toxicity (ARB, 1986c; U.S. EPA, 1994a).
A chronic non-cancer Reference Exposure Level (REL) of 3.5 g/m3
is listed for cadmium in the California Air Pollution Control
Officers Association Air Toxics "Hot Spots" Program, Revised
1992 Risk Assessment Guidelines. The toxicological endpoints considered
for chronic toxicity are the kidney and respiratory system (CAPCOA, 1993).
The U.S. EPA has not established a Reference Concentration (RfC) but has
determined an oral Reference Dose (RfD) for cadmium in drinking water of
5 x 10-4 milligram per kilogram per day (mg/kg/d) and the RfD
in food is 0.001 mg/kg/d, both based on significant proteinuria in humans.
The U.S. EPA estimates that consumption of these levels or less, over a
lifetime, would not likely result in the occurrence of chronic non-cancer
effects (U.S. EPA, 1994a).
Human developmental studies are limited, although there is some evidence to suggest that maternal cadmium exposure may result in decreased birthweights (U.S. EPA, 1994a). Cadmium oral exposure induces testicular necrosis in experimental animals, ovarian damage, infertility, placental toxicity and embryo and fetotoxicity and teratogenicity. Developmental effects such
as decreased weight gain and neurobehavioral deficits have been reported in animal studies
(ARB, 1986c). The State of California under Proposition 65 has determined
that cadmium is a male reproductive and developmental toxicant (CCR, 1997).
Cancer: Epidemiological evidence strongly supports an association between
cadmium exposure and neoplasia, including respiratory and renal cancers
(ARB, 1986c). Cancer resulting from inhalation exposure to several forms
of cadmium has been reported in animal studies, while animal ingestion
studies have usually proved negative (U.S. EPA, 1994a).
The U.S. EPA classified cadmium in Group B1: Probable human carcinogen, based
on human and animal studies showing an increase of lung cancer, and has established an inhalation potency value of 1.8 x 10-3 (microgram per cubic meter)-1. The U.S. EPA estimates that if an individual were to breathe air containing cadmium at 6 x 10-4 g/m3, over a lifetime, that person would theoretically have no more than a 1 in 1 million increased chance of developing cancer (U.S. EPA, 1994a). The International Agency for Research on Cancer classified cadmium and cadmium compounds in Group 1: Human carcinogen based on epidemiological evidence of carcinogenicity in humans and carcinogenic effects observed
in animals (IARC, 1993b). There is limited evidence in experimental
animals for the carcinogenicity of cadmium metal (HSDB, 1995).
The State of California has determined under AB 1807 and Proposition
65 that cadmium and cadmium compounds are carcinogens (ARB, 1986c; CCR,
1996). The inhalation potency factor that has been used as a basis for
regulatory action in California is 4.2 x 10-3 (micrograms per
cubic meter )-1 (OEHHA, 1994). In other words, the potential
excess cancer risk for a person exposed over a lifetime to 1 microgram
per cubic meter of cadmium is estimated to be no greater than 4,200 in
1 million (OEHHA, 1994).
Insert landscape table (filename: cadmitbl.wpd)
TABLE I - PHYSICAL PROPERTIES OF CADMIUM COMPOUNDS
Molecular Formula & Substance Name |
CAS Registry Number |
Synonyms |
Color Crystals |
Molecular Weight |
Boiling Point oC |
Melting Point oC |
Density/Specific Gravity |
Solubility in water |
C4H6CdO4
cadmium acetate |
543-90-8 |
cadmium diacetate |
colorless, mono-clinic |
230.49 |
decomposes |
256 |
2.01 |
soluble |
CCdO3
cadmium carbonate |
513-78-0 |
--- |
powder or rhombohedral leaflets |
174.42 |
decomposes at 500 |
--- |
4.26 |
insoluble |
CdCl2
cadmium chloride |
10108-64-2 |
cadmium dichloride |
hygroscopic rhombohedral |
183.32 |
960 |
568 |
4.05 |
soluble |
CdF2
cadmium fluoride |
7790-79-6 |
--- |
cubic, white |
150.41 |
1758 |
1049 |
6.33 |
soluble |
CdO
cadmium oxide |
1306-19-0 |
--- |
amorphous, brown |
128.4 |
1559 |
<1,426 |
6.95 |
insoluble |
Br2Cd
cadmium bromide |
7789-42-6 |
--- |
pearly, hexagonal |
272.22 |
963 |
566 |
5.19 |
soluble |
CdSO4
cadmium sulfate |
10124-36-4 |
--- |
rhombic, white |
208.46 |
--- |
1000 |
4.69 |
soluble |
CDs
cadmium sulfide |
1306-23-6 |
cadmium orange |
yellow, orange |
144.46 |
sublimes in N2 |
1,750 at 100 atm |
4.82 |
insoluble |
CdCl2O6
cadmium chlorate |
--- |
--- |
colorless |
279.31 |
--- |
80 |
2.28 |
--- |
CdN2O6
cadmium nitrate |
10325-94-7 |
cadmium dinitrate |
white, prismatic needles |
236.42 |
132 |
350 |
2.46 |
soluble |
Cd3O8P24H2O
cadmium phosphate |
13477-17-3 |
--- |
amorphous or colorless |
599.22 |
--- |
1500 |
--- |
--- |
C14H10CdO6
cadmium salicylate |
19010-79-8 |
--- |
monohydrate small needles |
386.64 |
--- |
242 |
--- |
soluble |
C2CdN2
cadmium cyanide |
--- |
--- |
crystals or white powder |
164.45 |
--- |
--- |
2.23 |
soluble |
(ARB, 1986; Sax, 1989; Merck, 1989)